Advanced Enzyme Technologies Ltd

NSE: ADVENZYMES · BSE: 540025 · Pharmaceuticals & Biotechnology · 62 announcements

Share price: ₹272.05
Market cap: ₹3,046 Cr
Revenue (annual): ₹745.8 Cr
Net profit (annual): ₹168.7 Cr
P/E (TTM): 18.4×Sector 47.4×
Promoter holding: 43.24%-0.02% QoQ
FII holding: 26.70%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

6 May 2026 18:42 IST BSE

Advanced Enzyme Technologies Credit Rating

Advanced Enzyme Technologies Ltd received credit rating reaffirmations from CRISIL for ₹100 Crore in bank facilities. The long-term rating is CRISIL A+/Stable and short-term rating is CRISIL A1+, reflecting maintained creditworthiness.

Value: ₹100.0 Cr

Read the filing ↗